Skip to main content
OpenTrials
Completed

NCT Number: NCT07723365

Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas

Twenty patients were included, comprising 11 women (55%) and 9 men (45%), with a mean age of 63.1 years. Chronic sun exposure was identified in 18 patients (90%). The lower eyelid was the most commonly affected site in 9 cases (45%). Basal cell carcinoma accounted for 15 tumors (75%), followed by squamous cell carcinoma in 5 cases (25%). Wide local excision with histopathological margin control was performed in all patients (20/20, 100%), and orbital exenteration was required in 1 case (5%). Reconstruction was achieved mainly using local flaps in 12 patients (60%). Ectropion occurred in 2 patients (10%). No local recurrence was observed during a mean follow-up of 22 months.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Oujda

Oujda, 60000, Morocco

About this study

This retrospective study was conducted over a three-year period, from January 2023 to December 2025, and included 20 patients with eyelid carcinomas who underwent surgical treatment in the Department of Plastic and Reconstructive Surgery at Mohammed VI University Hospital. Demographic, clinical, histological, therapeutic, and outcome data were analyzed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patient with carcinoma

Exclusion criteria

  • no exclusion criteria

Treatment and study plan

Primary outcomes

  1. Eyelid carcinomas

    Time frame: from January 2023 to December 2025

Sponsors and collaborators

Lead sponsor

Mohammed VI University Hospital

Other

Registry information

Official study title

Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas: A Three-Year Retrospective Case Series From Eastern Morocco

Acronym: epidemiology

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 23, 2026
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.